By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084



Company News
Advaxis, Inc.'s Lm-LLO Immunotherapy Platform To Be Featured In Three Poster Presentations At The 2015 American Association for Cancer Research Annual Meeting 3/19/2015 7:43:34 AM
Advaxis, Inc. Announces First Patient Treated In Phase 1/2 Dose-Escalation Study Of ADXS-HPV For Recurrent Cervical Cancer 3/19/2015 7:18:48 AM
Advaxis, Inc. Presents Preliminary Data From A Phase I/II Trial Of ADXS-HPV In HPV-Associated Anal Cancer In Combination With Chemoradiation Showing Complete Response And No Recurrences To Date In All Treated Patientsa 3/16/2015 7:15:21 AM
Gynecologic Oncology Group Commences Enrollment In Stage 2 Of GOG-0265 Clinical Trial 3/11/2015 7:29:15 AM
Advaxis, Inc. To Present At The 27th Annual ROTH Conference 3/5/2015 7:55:59 AM
Advaxis, Inc. To Present At The Cowen and Company 35th Annual Health Care Conference 3/2/2015 7:44:29 AM
Advaxis, Inc. To Present At International Anal Neoplasia Society Scientific Meeting 2015 2/26/2015 8:40:32 AM
Advaxis, Inc. Completes $23 Million Financing 2/18/2015 11:06:25 AM
Advaxis, Inc. Appoints Mayo Pujols Vice President, Manufacturing 2/13/2015 10:19:20 AM
Advaxis, Inc. Forms Clinical Trial Collaboration With Incyte Corporation (INCY) To Evaluate Investigational Combination Of Two Novel Cancer Immunotherapies For Early Stage Cervical Cancer 2/11/2015 7:56:49 AM